Diabetes drug News
In people with Type 2 diabetes, NAFLD is common and can progress to a severe liver disease known as non-alcoholic steatohepatitis (NASH).
This is a good news for all those people who want to shed their extra kilos.
This is the first time that a triple receptor drug has been used which acts in multiple ways to protect the brain from degeneration.
The new potential drugs have a completely different action than the most commonly prescribed anti-diabetic, Metformin, which acts on the liver to reduce glucose production
Over 70,000 people die from breast cancer in China every year, according to the national cancer centre.
Alzheimer`s is a progressive disease that destroys memory and other important mental functions.
A new study has revealed that diabetes drug may help prevent the risk of developing heart diseases.
A new study finds that an injectable drug which is widely used to lower blood sugar levels in type 2 diabetes helps in reducing the risk of dying from heart disease and advanced kidney disease.
The results showed that blood glucose levels of the group that underwent liraglutide prescription dropped to normal and their waist circumference was found to be smaller.
Pioglitazone belongs to a class of drugs called thiazolidinediones and helps to control blood sugar levels in patients with type 2 diabetes.
Researchers are likely to have uncovered a novel mechanism behind the ability of the common diabetes drug - metformin -- to inhibit the progression of pancreatic cancer.
The trials are expected to take five to seven years.
Treatment for heart failure is limited and prior efforts to treat patients with Type-2 diabetes drugs showed no benefit for heart failure.
Heart failure, a chronic condition in which the heart does not pump enough blood through the body, affects more than 5 million Americans.
A new study has revealed a new synthetic route to potential medicines for type 2 diabetes.
A drug currently used in Europe and Asia for treating gallstone-related spasms has been found effective in preventing the onset of Type-1 diabetes in mice, according to a study.
AstraZeneca Pharma on Thursday said it has launched diabetes drug 'Forxiga' in India.
Loading...